最重要的是，这样将使制药公司脱离该行业的价值之源，转而成为其他企业知识产权的资本密集型药品开发商和分销商。
Above all, it would shift pharmaceuticals companies away from the industry's source of value and turn them into capital-intensive developers and distributors of others' intellectual property.
最重要的是，这样将使制药公司脱离该行业的价值之源，转而成为其他企业知识产权的资本密集型药品开发商和分销商。
Above all, it would shift pharmaceuticals companies away from the industry's source of value and turn them into capital-intensive developers and distributors of others' intellectual property.
应用推荐